TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Fasting Blood Glucose From Baseline at 12 Months or More
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body sensation questionnaire (BSQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Differences in blood levels of catecholamines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Maximum Plasma Concentration (Cmax) of Pitavastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma Concentration Versus Time (Area Under the Curve, AUC0-inf) of Pitavastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Concentration (Tmax) of Pitavastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of Patients With PSA Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Necessity of rescue blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Percentage of participants using specific medications for the treatment of chronic pelvic pain (CPP) and/or dysmenorrhea (DYS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants who underwent surgical interventions for the treatment of CPP and/or DYS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants with complications associated with surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Hemoglobin A1C levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Esophageal pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local Control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Performance Category
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants died
Endpoint domain: Mortality/survival
Primary endpoint: FIT completion within 3 months
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Rate of correctly discriminated supraventricular tachyarrhythmia episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean pre-dialysis serum phosphate level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Measurement of genomic profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clearance of bone marrow micrometastases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Preterm Deliveries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Phosphocreatine Recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of device-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Average Palatability Rating
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: changes in evoked potentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: changes in functional MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Decrease in CDAI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Requirement for rescue hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Diameter of right internal jugular vein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Control of viral replication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBV Screening Test Results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with Treatment Decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain relief at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time Weighted Sum of Temperature Difference (WSTD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Microstream® dEtCO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip internal rotation range of motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Hamilton Depression Rating Scale (HAMD-17) Maier Subscale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SOMA Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Early detection of gastric cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: time to improvement and resolution of clinical signs and symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically Significant Improvement in HAQ-DI
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Postoperative trans-valvular mean gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in IL-6 specific transcripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Length of Time for Successful Advancement of Endotracheal Tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Percentage of participants with dose limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of MR techniques
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in FCG Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: cumulative incidence of cGVHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Etiology of acute appendicitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: QT/QTc Interval
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Composite in-hospital outcome
Endpoint domain: Mortality/survival
Primary endpoint: Composite follow-up outcome
Endpoint domain: Mortality/survival
Primary endpoint: Maximum change in pulse rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in pain VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Revised Memory and Behavior Problems Checklist (Reaction Subscale)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Zarit Burden Interview (12 Item)
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Veterans RAND 12-Item Health Survey (VR12)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of participants with any past 30 day vaping
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with any past 30 day nicotine vaping
Endpoint domain: Adverse events/effects
Primary endpoint: Accuracy of heart rate monitors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Criminal behavior
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Clinically significant endoscopic recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Changes in inflammatory biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: C peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Height and weight for age z-score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Human fecal elastase-1 in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Area Under the Serum Concentration-Time Curve (AUC0-77d)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined PR/ER response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changes in cardiovascular markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary Albumin/Creatinine Ratio (UACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Attendance at first scheduled clinic appointment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of sessions where buprenorphine positive urine results was recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Drug-related outcomes
Primary endpoint: Percentage of sessions where opioid free urine results were recorded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Drug-related outcomes
Primary endpoint: Total analgesic use after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Delay to recovery of normal painless walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of cases with tumour remains greater than 1g
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of Participants with bone turnover markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Posttraumatic Stress Disorder Scale (PDS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: actuarial elective nodal failure (ENF) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Changing of Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changing of Parkinson's Disease Questionnaire-8 (PDQ-8) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Percentage of Participants With an Anti-Hepatitis B Surface Antigen (HBsAg) Antibody Titer ≥10 mIU/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants With an Anti-Polyribosylribitol Phosphate (PRP) Antibody Titer ≥0.15 µg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Ferritin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Soluble Transferrin Receptor (sTfR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Alpha 1-Acid Glycoprotein (AGP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alteration of hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Pain reduction during IUD insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of IV Survival
Endpoint domain: Mortality/survival
Primary endpoint: Number of Responders with High-risk Sexual Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Time to onset of soothing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to onset of cooling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Diurnal Intraocular Pressure (IOP) at Week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of postoperative pneumolabyrinth
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of vertigo
Endpoint domain: Adverse events/effects
Primary endpoint: change in pure-tone bone conduction hearing thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes from baseline gingival index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of detected cancers with Gleason Score ≥7
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patency of the lacrimal passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disappearance of lacrimal sac swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants who require a revision
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Overall response after retreatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients with virological failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 14,15-DHET blood level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Exercise Performance - Distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise Performance - Duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative incidence of PTS in patients with an acute DVT
Endpoint domain: Mortality/survival
Primary endpoint: PE related quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Speed in the Timed 25 Feet Walk Test at Self-selected Speed (Without Exoskeleton)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distance Walked During the Six-minute Walk Test (Without Exoskeleton)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Demands as Assessed by Energy Expenditure (VO2-max) During the Timed 25 Feet Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in HIV medication adherence
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in frequency in attending HIV medical appointments
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in the percentage of compromised lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Area Under Concentration-Time Curve From Time Zero to the Last Quantifiable (AUC [0-last])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients Who Experience a False Positive ST Detection
Endpoint domain: Adverse events/effects
Primary endpoint: pharmacokinetics of SEN0014196
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on EGF pathway
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of serious mental illness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical sensitivity (true positive rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical specificity (true negative rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Constipation measured by Bristol stool scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Target tumor plasma ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Number of CD34+ cells collected following treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Proportion of newly diagnosed HCV patients linked to care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Occurrences of Pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of upper extremity skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Operative performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Intraoperative errors
Endpoint domain: Adverse events/effects
Primary endpoint: Breastfeeding Attitudes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Breastfeeding Motivation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Application Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of maximal workload during ergometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with normal gastric mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with Helicobacter pylori associated gastritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of patients with gastric atrophy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of Subjects With Local Injection Site Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Subjects Who Discontinue Study Drug or Withdraw From the Study
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Walking Distance During 6-Minute Walk Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expectant mothers satisfaction of prenatal care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Histopathology and nuclear morphometry of intraepithelial neoplasia lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sum of All Symptoms in Viruspositive Persons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sum of All Symptoms of All Persons That Fulfilled the Study
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of acute mountain sickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of women delivering in a health facility
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Number of Participants Reporting TEAEs and Infusion-Related Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Absence of grade 4 or 5 non-hematological or grade 5 hematological toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of major transplant related toxicities (Grades IV and IV)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in expressed emotion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in percentage of median body mass index (%mBMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response (CR or PR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients diagnosed with Intrauterine growth restriction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Change in clinical symptoms of traumatic brain injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline in Questionnaire about Process of Recovery (QPR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Orthopaedic outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hemofilter lifetime
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: scattered radiation reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Breast Tomosynthesis compared to standard mammography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early and sensitive diagnosis of Glycogen storage disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total quit rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in ASI total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: retention rate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Long-term safety of PA32540
Endpoint domain: Adverse events/effects
Primary endpoint: first episode of objectively documented VTE
Endpoint domain: Adverse events/effects
Primary endpoint: HCV Viral Load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure rate of central venous catheter insertion
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Successful Self-injections
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Antimicrobial resistance selection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Time Required for Intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Leak Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Infant Gastrointestinal Symptoms Questionnaire-13 (IGSQ-13) Index Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Strength of quadriceps femoris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in subjective burden
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Schirmer Test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of re-sternotomy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of reoperation on saphen venous/radial artery site
Endpoint domain: Adverse events/effects
Primary endpoint: Change from Baseline Cobb's Angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes